SARS-CoV-2 vaccine, mRNA-1273 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6y+ (EUA)
RxNorm 2610328

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2610328 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: SARS-CoV-2 vaccine, mRNA-1273 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6y+ (EUA).

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.05 mg/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) 0.05 mg/ML Injectable Suspension
Primary clinical definition
AUI:12759901
View
SY
SARS-CoV-2 vaccine, mRNA 1273 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6y+ (EUA)
AUI:12784291
View
PSN
SARS-CoV-2 vaccine, mRNA-1273 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6y+ (EUA)
AUI:12784292
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCDPrescribable

Semantic Clinical Drug (SCD):
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.05 mg/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) 0.05 mg/ML Injectable Suspension
(Atom ID: 12759901)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 0.05 MG/ML / SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5) 0.05 MG/ML Injectable Suspension
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2610328
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12759901
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
2610328
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{2610324} 2470232
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{2610327} 2610326
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{2610324} 2470232
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{2610327} 2610326
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
0.05 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-1273) / 0.05 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5))
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{2610324} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2610327} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
RXTERM FORM
Susp
The RxTerm dose form name for this drug
SYPrescribable

Synonym (SY):
SARS-CoV-2 vaccine, mRNA 1273 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6y+ (EUA)
(Atom ID: 12784291)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
SARS-CoV-2 vaccine, mRNA 1273 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6y+ (EUA)
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2610328
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12784291
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2610328
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
PSNPrescribable

Prescribable Name (PSN):
SARS-CoV-2 vaccine, mRNA-1273 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6y+ (EUA)
(Atom ID: 12784292)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
SARS-CoV-2 vaccine, mRNA-1273 bivalent original & OMICRON (BA.4/.5) Injectable Suspension, 6y+ (EUA)
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2610328
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12784292
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2610328
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

COVID-19 Vaccines


COVID-19 (coronavirus disease 2019) is an illness caused by a virus. This virus is a coronavirus called SARS-CoV-2. In the United States, there are several vaccines to prevent COVID-19. Some have been approved by the U.S. Food and Drug Administration (FDA). Others are being used under Emergency Use Authorization (EUA) from the FDA. All of these vaccines have met the FDA's scientific standards for safety, effectiveness, and manufacturing quality needed to support authorization or approval.

This page includes details about the vaccines and the vaccination program, including where you can find a vaccine.

Centers for Disease Control and Prevention


[Learn More]


* Please review the disclaimer below.